{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:00:40Z","timestamp":1762898440940,"version":"3.35.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11897-008-0017-x","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T07:20:42Z","timestamp":1223709642000},"page":"105-109","source":"Crossref","is-referenced-by-count":16,"title":["Adenosine A1 antagonists and the cardiorenal syndrome"],"prefix":"10.1007","volume":"5","author":[{"given":"Stephen S.","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,11]]},"reference":[{"key":"17_CR1","first-page":"F374","volume":"271","author":"V.S. Balakrishnan","year":"1996","unstructured":"Balakrishnan VS, Coles GA, Williams JD: Effects of intravenous adenosine on renal function in healthy human subjects. Am J Physiol 1996, 271(2 Pt 2):F374\u2013F381.","journal-title":"Am J Physiol"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"F1016","DOI":"10.1152\/ajprenal.00367.2005","volume":"290","author":"S.M. Kim","year":"2006","unstructured":"Kim SM, Mizel D, Huang YG, et al.: Adenosine as a mediator of macula densa-dependent inhibition of renin secretion. Am J Physiol Renal Physiol 2006, 290:F1016\u2013F1023.","journal-title":"Am J Physiol Renal Physiol"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/physrev.00031.2005","volume":"86","author":"V. Vallon","year":"2006","unstructured":"Vallon V, Muhlbauer B, Osswald H: Adenosine and kidney function. Physiol Rev 2006; 86:901\u2013940.","journal-title":"Physiol Rev"},{"key":"17_CR4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0022-3565(24)37711-0","volume":"286","author":"M. Gellai","year":"1998","unstructured":"Gellai M, Schreiner GF, Ruffolo RR Jr, et al.: CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity. J Pharmacol Exp Ther 1998, 286:1191\u20131196.","journal-title":"J Pharmacol Exp Ther"},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1072-7515(02)01136-5","volume":"194","author":"D.G. Lucas Jr","year":"2002","unstructured":"Lucas DG Jr, Hendrick JW, Sample JA, et al.: Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure. J Am Coll Surg 2002, 194:603\u2013609.","journal-title":"J Am Coll Surg"},{"key":"17_CR6","first-page":"F504","volume":"265","author":"V.S. Balakrishnan","year":"1993","unstructured":"Balakrishnan VS, Coles GA, Williams JD: A potential role for endogenous adenosine in control of human glomerular and tubular function. Am J Physiol 1993, 265(4 Pt 2):F504\u2013F510.","journal-title":"Am J Physiol"},{"key":"17_CR7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(99)00532-X","volume":"35","author":"S.S. Gottlieb","year":"2000","unstructured":"Gottlieb SS, Skettino SL, Wolff A, et al.: The effects of BG9719 (CVT-124), an A1 adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in congestive heart failure patients. J Am Coll Cardiol 2000, 35:56\u201359.","journal-title":"J Am Coll Cardiol"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","volume":"105","author":"S.S. Gottlieb","year":"2002","unstructured":"Gottlieb SS, Brater DC, Thomas I, et al.: BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002, 105:1348\u20131353.","journal-title":"Circulation"},{"key":"17_CR9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2007.07.019","volume":"50","author":"M.M. Givertz","year":"2007","unstructured":"Givertz MM, Massie BM, Fields TK, et al.: The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 2007, 50:1551\u20131560.","journal-title":"J Am Coll Cardiol"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cardfail.2007.08.006","volume":"13","author":"H.C. Dittrich","year":"2007","unstructured":"Dittrich HC, Gupta DK, Hack TC, et al.: The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 2007, 13:609\u2013617.","journal-title":"J Card Fail"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ejheart.2007.07.003","volume":"9","author":"J.G. Cleland","year":"2007","unstructured":"Cleland JG, Coletta AP, Abdellah AT, et al.: Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF. Eur J Heart Fail 2007, 9:850\u2013853.","journal-title":"Eur J Heart Fail"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jacc.2007.03.059","volume":"50","author":"B. Greenberg","year":"2007","unstructured":"Greenberg B, Thomas I, Banish D, et al.: Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol 2007, 50:600\u2013606.","journal-title":"J Am Coll Cardiol"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","volume":"95","author":"H. Funaya","year":"1997","unstructured":"Funaya H, Kitakaze M, Node K, et al.: Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997, 95:1363\u20131365.","journal-title":"Circulation"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/CIRCULATIONAHA.107.694596","volume":"115","author":"H. Funakoshi","year":"2007","unstructured":"Funakoshi H, Zacharia LC, Tang Z, et al.: A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction. Circulation 2007, 115:2307\u20132315.","journal-title":"Circulation"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1161\/CIRCULATIONAHA.106.620211","volume":"114","author":"H. Funakoshi","year":"2006","unstructured":"Funakoshi H, Chan TO, Good JC, et al.: Regulated over-expression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Circulation 2006, 114:2240\u20132250.","journal-title":"Circulation"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjp.0707319","volume":"151","author":"P. Kalk","year":"2007","unstructured":"Kalk P, Eggert B, Relle K, et al.: The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5\/6 nephrectomy without affecting blood pressure. Br J Pharmacol 2007, 151:1025\u20131032.","journal-title":"Br J Pharmacol"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"H1469","DOI":"10.1152\/ajpheart.00181.2005","volume":"290","author":"A.R. Lankford","year":"2006","unstructured":"Lankford AR, Yang JN, Rose\u2019Meyer R, et al.: Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2006, 290:H1469\u2013H1473.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0008-6363(01)00471-0","volume":"53","author":"R. Zucchi","year":"2002","unstructured":"Zucchi R, Cerniway RJ, Ronca-Testoni S, et al.: Effect of cardiac A(1) adenosine receptor overexpression on sarcoplasmic reticulum function. Cardiovasc Res 2002, 53:326\u2013333.","journal-title":"Cardiovasc Res"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.yjmcc.2007.08.014","volume":"43","author":"F.N. Salloum","year":"2007","unstructured":"Salloum FN, Das A, Thomas CS, et al.: Adenosine A1 receptor mediates delayed cardioprotective effect of sildenafil in mouse. J Mol Cell Cardiol 2007, 43:545\u2013551.","journal-title":"J Mol Cell Cardiol"},{"key":"17_CR20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.103.057943","volume":"308","author":"J.A. Auchampach","year":"2004","unstructured":"Auchampach JA, Jin X, Moore J, et al.: Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs. J Pharmacol Exp Ther 2004, 308:846\u2013856.","journal-title":"J Pharmacol Exp Ther"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.2174\/092986706779010306","volume":"13","author":"P.G. Baraldi","year":"2006","unstructured":"Baraldi PG, Romagnoli R, Preti D, et al.: Ligands for A2B adenosine receptor subtype. Curr Med Chem 2006, 13:3467\u20133482.","journal-title":"Curr Med Chem"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"K.A. Jacobson","year":"2006","unstructured":"Jacobson KA, Gao ZG: Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 2006, 5:247\u2013264.","journal-title":"Nat Rev Drug Discov"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","volume":"29","author":"M.A. Schwarzschild","year":"2006","unstructured":"Schwarzschild MA, Agnati L, Fuxe K, et al.: Targeting adenosine A2A receptors in Parkinson\u2019s disease. Trends Neurosci 2006, 29:647\u2013654.","journal-title":"Trends Neurosci"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1517\/13543784.16.10.1601","volume":"16","author":"S. Bar-Yehuda","year":"2007","unstructured":"Bar-Yehuda S, Silverman MH, Kerns WD, et al.: The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis. Expert Opin Investig Drugs 2007, 16:1601\u20131613.","journal-title":"Expert Opin Investig Drugs"},{"key":"17_CR25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1213\/01.ane.0000267260.00384.d9","volume":"105","author":"T.J. Gan","year":"2007","unstructured":"Gan TJ, Habib AS: Adenosine as a non-opioid analgesic in the perioperative setting. Anesth Analg 2007, 105:487\u2013494.","journal-title":"Anesth Analg"},{"key":"17_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.phrs.2007.04.011","volume":"56","author":"N. Hosseinmardi","year":"2007","unstructured":"Hosseinmardi N, Mirnajafi-Zadeh J, Fathollahi Y, Shahabi P: The role of adenosine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled seizures in rats. Pharmacol Res 2007, 56:110\u2013117.","journal-title":"Pharmacol Res"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-008-0017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-008-0017-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-008-0017-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T18:03:17Z","timestamp":1738432997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-008-0017-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s11897-008-0017-x","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"type":"print","value":"1546-9530"},{"type":"electronic","value":"1546-9549"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}